Also, previous studies have shown that TNFα antagonists are associated with risk reduction in cardiovascular events among patients with rheumatoid arthritis, psoriasis and psoriatic arthritis [31,32,33]. The gene discussed is TNF; the disease is rheumatoid arthritis.